[HTML][HTML] Pneumococcal vaccine for adults aged≥ 19 years: recommendations of the Advisory Committee on Immunization Practices, United States, 2023

M Kobayashi - MMWR. Recommendations and Reports, 2023 - cdc.gov
This report compiles and summarizes all published recommendations from CDC's Advisory
Committee on Immunization Practices (ACIP) for use of pneumococcal vaccines in adults …

Pneumococcal vaccination—a literature review and practice guideline update

C El‐Beyrouty, R Buckler, M Mitchell… - … : The Journal of …, 2022 - Wiley Online Library
Streptococcus pneumoniae (pneumococcus) remains a significant cause of both mild
infections such as otitis media, sinusitis, and bronchitis and more severe manifestations …

PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children

TJ Chapman, L Olarte, G Dbaibo… - Expert review of …, 2024 - Taylor & Francis
Introduction Streptococcus pneumoniae is a causative agent of pneumonia and acute otitis
media (AOM), as well as invasive diseases such as meningitis and bacteremia. PCV15 …

[HTML][HTML] Burden of pneumococcal disease due to serotypes covered by the 13-valent and new higher-valent pneumococcal conjugate vaccines in the United States

L Huang, M Wasserman, L Grant, R Farkouh, V Snow… - Vaccine, 2022 - Elsevier
The addition of pneumococcal conjugate vaccines (PCVs) to the United States (US) national
immunization program led to significant reductions in incidence, mortality, and associated …

Validation of Fourier transform infrared spectroscopy for serotyping of Streptococcus pneumoniae

I Passaris, N Mauder, M Kostrzewa… - Journal of clinical …, 2022 - Am Soc Microbiol
Fourier transform infrared (FT-IR) spectroscopy (IR Biotyper; Bruker) allows highly
discriminatory fingerprinting of closely related bacterial strains. In this study, FT-IR …

[HTML][HTML] Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine coadministered with quadrivalent influenza vaccine: a phase 3 randomized trial

K Cannon, JF Cardona, K Yacisin, A Thompson… - Vaccine, 2023 - Elsevier
Introduction Older adults are at increased risk of adverse outcomes from pneumococcal
disease and influenza infections. Vaccination is an established strategy for preventing both …

[HTML][HTML] Comparison of pneumococcal immunogenicity elicited by the PCV13 and PCV15 vaccines in adults 18 through 49 years of age

I Kanevsky, N Surendran, K McElwee, L Lei, W Watson… - Vaccine, 2023 - Elsevier
Aim Pneumococcal conjugate vaccines (PCV13, PCV15, PCV20) effectively target the
capsular polysaccharides of the most common disease-causing Streptococcus pneumoniae …

Aktualisierung der Empfehlungen der STIKO zur Standardimpfung von Personen≥ 60 Jahre sowie zur Indikationsimpfung von Risikogruppen gegen Pneumokokken …

J Schlaberg, S Vygen-Bonnet, A Falman, J Wilhelm… - 2023 - edoc.rki.de
Erkrankungen durch S. pneumoniae gehören zu den häufigsten bakteriellen
Atemwegsinfektionen weltweit. Auch in Deutschland sind Hospitalisierungen und Todesfälle …

Evaluation of the efficacy, safety and influencing factors of concomitant and sequential administration of viral respiratory infectious disease vaccines: a systematic …

D Lu, Y Han, R Xu, M Qin, J Shi, C Zhang… - Frontiers in …, 2023 - frontiersin.org
Background There is no clear conclusion on the immunogenicity and adverse events of
concomitant administration the viral respiratory infectious disease vaccines. We aimed to …

Precision vaccinology for infectious diseases

M Rahman, M Adeli, HE Schellhorn… - Frontiers in …, 2024 - frontiersin.org
In the ever-evolving landscape of infectious diseases, the quest for effective preventive
measures has reached a pivotal stage. The rise of precision vaccinology signifies a …